Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC18A3 | Q16572 | 1/20 | 0.35 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.35 |
| ▸ | BCHE | P06276 | 1/20 | 0.34 |
| ▸ | ACHE | P22303 | 1/20 | 0.34 |
| ▸ | HTR2C | P28335 | 6/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.32 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.31 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.31 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.31 |
| ▸ | PLG | P00747 | 2/20 | 0.31 |
| ▸ | QDPR | P09417 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Piperazine SCHEMBL27877942 | 0.83 | — | — | |
| SCHEMBL24446604 | 0.82 | SLC6A2 (0.30) | — | |
| SCHEMBL231964 | 0.82 | SLC18A3 (0.32) | SLC18A3SIGMAR1 | |
| SCHEMBL3828819 | 0.81 | SLC18A3 (0.31) | SLC18A3SIGMAR1 | |
| Hydrochloric Acid SCHEMBL28354165 | 0.81 | SLC18A3 (0.31) | SLC18A3SIGMAR1HTR2C | |
| SCHEMBL4754795 | 0.79 | — | — | |
| SCHEMBL13767655 | 0.78 | SLC18A3 (0.36) | SLC18A3SIGMAR1BCHEACHEHTR2C | |
| SCHEMBL22038 | 0.75 | — | — | |
| Lithium SCHEMBL31113350 | 0.74 | — | — | |
| SCHEMBL121612 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025128893-A1 | FUSED QUINONE COMPOUNDS | ACUREX BIOSCIENCES CORPORATION (US) | 2025-06-19 | — | — | WO | disclosed |
| WO-2022188823-A1 | TRICYCLIC HPK1 INHIBITOR AND USE THEREOF | 山东轩竹医药科技有限公司 | 2022-09-15 | — | — | WO | disclosed |